To find out more about our technology and partnering opportunities please email us. NEURODEGENERATIVE AND CNS DISEASE SERVICES. In the pharmaceutical industry and plays an active role in a variety of research consortia. If you would like to discuss a potential partnership with us then please contact us.

G2C is an international collaborative program initiated by Professor Seth Grant. And supported by the Wellcome Trust following the discovery that multiprotein complexes formed by intracellular proteins and neurotransmitter receptors were important for neuronal plasticity and behaviour. G2C collaborators include scientists with compleme.

CognitionNet investigates brain mechanisms of cognition at the molecular, cellular, neural network and behavioural level, both from a basic and a clinical perspective. Cognitive control in neuropsychiatric disease. Further enhances the impact of cognitive dysfunction on society. In coming decades this burden will grow into one of most pressing and costly problems of the EU. CognitionNet builds on our knowledge. Will deliver 14 skilled trainees.

Welcome to Le Novère lab. The main biological focus of the group is to understand how cellular and molecular systems interpret signals from their environment and adapt their behaviour as a consequence. This entails understanding how the various cells receive and transduce signals, the interplay of different signalling pathways, and the final outcome for cell physiology, including gene expression and cell fate. If you want to know more about our research.

SynSys aims at molecular analysis of synapse function and dynamic modeling. The perspective is to generate a blueprint for the discovery of novel pathways and targets that enable rational strategies to design therapies for human brain disease. Is the common consortium database that stores synatic protein data and makes the data available for computational analysis. Available to SynSys Project partners.